new indications for glp 1 drugs GLP-1 Drug Overdose GLP-1 Market Industry Trends and

The oral form prepared by Semaglutide and absorption enhancer SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate), became the first oral GLP-1RA approved by the FDA for the treatment of T2DM (Kalra and Sahay, 2020

The primary outcomes of the study were changes in HbA1c, body weight, and FPG from baseline, while safety outcomes were selected as secondary outcomes

Gates and K

Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjoth TV et al (2015) Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial

[DOI] [PubMed] [Google Scholar] 29.Zhang Q., Delessa C.T., Augustin R., Bakhti M., Collden G., Drucker D.J., Feuchtinger A., Caceres C.G., Grandl G., Harger A., et al